Skip to main content
Log in

Clinicopathological features of malignancy in hepatocellular carcinoma

  • First International Symposium on Treatment of Liver Cancer Kobe, Japan, 15–16 November 1987 Session 3: Surgery
  • Malignancy of Hepatocellular Carcinoma, Prognosis, Tumor Growth Rate
  • Published:
Cancer Chemotherapy and Pharmacology Aims and scope Submit manuscript

Summary

The clinicopathological features showing the malignancy of hepatocellular carcinoma were investigated by retrospectively analyzing the postoperative prognosis after hepatic resection. The long-term prognosis was stongly affected by the existence of portal tumor invasion or intrahepatic metastasis as indicated by the following results. The 3-year cumulative survival rates were 61% and 38% for patients in portal vein tumor invasion groups (Vp0 and Vp1 (P<0.05). No patients with Vp2 or Vp3 could survive beyond 3 years after hepatic resection. Similarly, patients with intrahepatic metastasis IM0 showed a better prognosis, compared to those with IM2 or IM3 (P<0.05). In addition, the grade of tumor cell anaplasia to some extent affected the prognosis, but not the tumor growth pattern at the tumor/non-tumor boundary. The tumor growth rate, estimated by the α-fetoprotein doubling time, was not connected with venous invasion or intrahepatic metastasis, but it became shorter at the time of a recurrence. It is concluded that, from the standpoint of a long-term prognosis, the pathological features showing malignancy appear in venous invasion and intrahepatic metastasis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Collins VP, Loeffler RK, Tivey H (1956) Observations on growth rates of human tumors. Am J Roentgenol 76: 988

    Google Scholar 

  2. Edmondson HA, Steiner P (1954) Primary carcinoma of the liver. A study of 100 cases among 48 900 necropsies. Cancer 4: 462

    Google Scholar 

  3. Hattori T, Hosokawa Y, Fukuda M, Sugihara H, Hamada S, Takamatsu T, Nakanishi K, Tsuchihashi Y, Kitamura T, Fujita S (1984) Analysis of DNA ploidy patterns of gastric carcinoma of Japanese. Cancer 54: 159

    Google Scholar 

  4. Liver Cancer Study Group of Japan (1983) The general rules for the clinical and pathological study of primary liver cancer. Kanahara Press, Tokyo

    Google Scholar 

  5. Matsumoto Y, Suzuki T, Asada I, Ozawa K, Tobe T, Honjo I (1982) Clinical classification of hepatoma in Japan according to serial changes in serum alpha-fetoprotein levels. Cancer 49: 354

    Google Scholar 

  6. Nakashima T, Kojiro M (1986) Pathologic characteristic of hepatocellular carcinoma. Semin Liver Dis 6: 259

    Google Scholar 

  7. Ozawa K, Ida T, Yamada T, Yamaoka Y, Takasan H, Honjo I (1975) Oral glucose tolerance test in patients with jaundice. Surg Gynecol Obstet 140: 582

    Google Scholar 

  8. Schirrmacher U (1985) Adv Cancer Res 43: 1

    Google Scholar 

  9. Schwartz M (1961) A biomathematical approach to clinical tumor growth. Cancer 14: 1272

    Google Scholar 

  10. Shew JC, Sung JL, Chen DS, Yang PM, Lai MY, Lee CS, Hsu HC, Chuang CN, Yang PC, Wang TH, Lin JT, Lee CZ (1986) Growth rate of asymptomatic hepatocellular carcinoma and its clinical implications. Gastroenterology 89: 259

    Google Scholar 

  11. Yamanaka N, Okamoto E, Kuwata K, Tanaka N (1984) A multi regression equation for prediction of posthepatectomy liver failure. Ann Surg 200: 658

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Tanaka, J., Tobe, T., Morino, T. et al. Clinicopathological features of malignancy in hepatocellular carcinoma. Cancer Chemother. Pharmacol. 23 (Suppl 1), S96–S100 (1989). https://doi.org/10.1007/BF00647250

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00647250

Keywords

Navigation